Evidence map›Paper›PMID 31516814›Full record

ArticlePreventive medicine reports2019

Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study.

Kia Skrine Jeffers, Yelba Castellon-Lopez, Jonathan Grotts, Carol M Mangione, Tannaz Moin, Chi-Hong Tseng, Norman Turk, Dominick L Frosch, Keith C Norris, Christopher C Duke and 2 more

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kia Skrine JeffersSchool Nursing, UCLA, Los Angeles, CA, United States of America.
Yelba Castellon-LopezDepartment of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Jonathan GrottsDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Carol M MangioneDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Tannaz MoinDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Chi-Hong TsengDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Norman TurkDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Dominick L FroschPalo Alto Medical Foundation, Palo Alto, CA, United States of America.
Keith C NorrisDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
Christopher C DukeAltarum Institute, Ann Arbor, MI, United States of America.
Gerardo MorenoDepartment of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
O Kenrik DuruDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America.
University of California, Los Angeles · USAltarum Institute · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CATHERINE A SARKISIAN · 2002 to 2026
$19.7M
A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the DPPR18DK105464 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DURU, OBIDIUGWU KENRIK, MANGIONE, CAROL M · 2015 to 2019
$3.3M
Health IT decision support to improve medication management safety and qualityK23AG042961 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORENO, GERARDO · 2012 to 2016
$699k
NCATS NIH HHS UL1 TR001881NIA NIH HHS K23 AG042961NIA NIH HHS P30 AG021684NIDDK NIH HHS R18 DK105464
6 · The paper itself

Abstract

The Diabetes Prevention Program (DPP) is a 12-month behavior change program designed to increase physical activity and improve dietary patterns among patients at risk for Type 2 diabetes, in order to facilitate modest weight loss and improve cardio-metabolic profiles. It is unknown whether baseline patient activation is related to increased DPP uptake, and whether DPP attendance leads to subsequent improvement in patient activation. We analyzed data from 352 adult participants in the Prediabetes Informed Decisions and Education (PRIDE) trial of shared decision-making (SDM) in diabetes prevention, collected from November 2015 through September 2017. PRIDE participants completed baseline and 4-month follow-up surveys, including the Altarum Consumer Engagement (ACE) Measure™ of patient activation. We tracked DPP attendance over 8 months using data from partnering DPP providers. In multivariate models, we measured whether self-reported baseline activation was associated with DPP "uptake" (1+ session attended) or DPP "attendance" (9+ sessions). We also examined whether DPP attendance was associated with change in activation at 4-months follow-up. We did not find an association between baseline activation and DPP uptake or attendance. However, we did find that DPP attendance was associated with an increase in the overall ACE score (6.68 points, 95% CI 1.97-11.39,

Indexed as

Diabetes mellitusDiabetes Prevention ProgramPharmacistsShared decision-making

Identifiers

PMID31516814
PMCPMC6732720
OpenAlexW2963118025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.